Exhibit 107
Calculation of Filing Fee Tables
Form F-1
Virax Biolabs Group Limited
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security | Security | Fee | Amount | Proposed | Maximum | Fee | Amount of | |||||||||||||||||||||||
Type | Class | Calculation | Registered(1) | Maximum | Aggregate | Rate | Registration | |||||||||||||||||||||||
Title | or Carry | Offering | Offering | Fee | ||||||||||||||||||||||||||
Forward Rule | Price Per | Price(1) | ||||||||||||||||||||||||||||
Unit(2) | ||||||||||||||||||||||||||||||
Newly Registered Securities |
| |||||||||||||||||||||||||||||
Fees to be | Equity | Ordinary | Rule 457(c) | 5,825,000 | $1.43 | $8,329,750 | 0.0001102 | $917.94 | ||||||||||||||||||||||
Paid | shares, par value |
|||||||||||||||||||||||||||||
US$0.0001 per |
||||||||||||||||||||||||||||||
share(3) | ||||||||||||||||||||||||||||||
Total Offering Amounts | $8,329,750 | 0.0001102 | $917.94 | |||||||||||||||||||||||||||
Total Fees Previously Paid | ||||||||||||||||||||||||||||||
Total Fee Offsets | ||||||||||||||||||||||||||||||
Net Fee Due | $917.94 |
1. | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the Securities Act), the ordinary shares being registered hereunder include such indeterminate number of ordinary shares as may be issuable with respect to such ordinary shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. |
2. | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) promulgated under the Securities Act, based upon the average of the high ($1.48) and low ($1.38) prices of the ordinary shares as reported on the Nasdaq Capital Market on November 17, 2022. |
3. | Comprised of (i) 1,165,000 PIPE Shares (as defined in the Registration Statement), (ii) 1,165,000 Pre-Funded Warrant Shares (as defined in the Registration Statement), and (iii) 3,495,000 Warrant Shares (as defined in the Registration Statement). |